JAM2 Activation – Leaky Gut Syndrome
Understanding Leaky Gut Syndrome
Leaky Gut Syndrome (also known as increased intestinal permeability) occurs when the tight junctions between cells in the intestinal lining become compromised. This allows undigested food particles, bacterial toxins, and other substances to pass into the bloodstream, potentially triggering systemic inflammation and immune responses.
Increased intestinal permeability is well-documented in scientific literature and is associated with conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), celiac disease, and various autoimmune disorders. While not everyone experiences symptoms, it is increasingly recognized as a contributing factor in chronic health issues. Estimates suggest that a significant portion of the population may have some degree of compromised gut barrier function, particularly with aging, poor diet, stress, or antibiotic use.
There is also growing evidence linking leaky gut to increased permeability of the blood-brain barrier in older age. The same inflammatory processes and tight junction disruptions that weaken the intestinal barrier may similarly affect brain endothelial cells, potentially contributing to neuroinflammation and age-related cognitive decline.
The Role of JAM2 Protein
JAM2 (Junctional Adhesion Molecule 2) is a key protein in the formation and maintenance of tight junctions between epithelial cells. It plays a critical role in cell adhesion, barrier integrity, and regulating what can pass between cells. We believe that enhancing JAM2 expression or function can strengthen cellular junctions in the gut lining, reducing unwanted permeability. By increasing JAM2 levels — or even optimizing the gene for better junction performance — it may be possible to restore a healthier, more selective barrier. Disclaimer: All research at Bio Voyager is preclinical and conducted in laboratory settings using human cell cultures. Our work is not intended for human use at this stage.
Our Three Research Approaches for JAM2 Activation
We are pursuing three complementary strategies to increase JAM2 production and improve gut barrier function:
Engineered Lactobacillus Probiotics
We are developing genetically modified strains of Lactobacillus (naturally occurring beneficial gut bacteria) that carry the JAM2 gene. These modified bacteria can produce and secrete JAM2 protein directly in the gut environment. This approach aims to enrich the epithelial wall, promoting stronger cell-to-cell adhesions where they are needed most — in the intestinal lining.
High-Throughput Screening (HTS)
for Small-Molecule Activators
Using our advanced GFP-based promoter-reporter assays in human cell cultures, we screen thousands of natural and synthetic compounds to identify those that significantly increase JAM2 gene expression. Promising molecules will be prioritized for further development as potential nutraceutical or pharmaceutical candidates.
AAV Gene Therapy
We are designing Adeno-Associated Virus (AAV) vectors to deliver the JAM2 gene directly into intestinal epithelial cells. This approach aims to increase long-term endogenous production of JAM2 protein for sustained barrier repair.
Partnership Opportunities
We offer licensing of discovered compounds, custom research, and technology transfer for all three approaches.
HTS Screening Project: Start at $40,000 – $150,000 + 5% royalty
Gene Therapy Development: Custom pricing (typically $1M – $2M) + 5% royalty
Full technology transfer and offshore lab setup available
Head Office
Tampa
Florida, US
Call Now
312-730-2562
786-307-1256
Email Us
dr.nikolic@ufl.edu